Cargando…

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets

Detalles Bibliográficos
Autores principales: Wong, David C. S., Harvey, Joshua P., Jurkute, Neringa, Thomasy, Sara M., Moosajee, Mariya, Yu-Wai-Man, Patrick, Gilhooley, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Neuro-Ophthalmology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645107/
https://www.ncbi.nlm.nih.gov/pubmed/37974363
http://dx.doi.org/10.1097/WNO.0000000000001830
_version_ 1785147321773719552
author Wong, David C. S.
Harvey, Joshua P.
Jurkute, Neringa
Thomasy, Sara M.
Moosajee, Mariya
Yu-Wai-Man, Patrick
Gilhooley, Michael J.
author_facet Wong, David C. S.
Harvey, Joshua P.
Jurkute, Neringa
Thomasy, Sara M.
Moosajee, Mariya
Yu-Wai-Man, Patrick
Gilhooley, Michael J.
author_sort Wong, David C. S.
collection PubMed
description
format Online
Article
Text
id pubmed-10645107
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Journal of Neuro-Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-106451072023-11-15 OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets Wong, David C. S. Harvey, Joshua P. Jurkute, Neringa Thomasy, Sara M. Moosajee, Mariya Yu-Wai-Man, Patrick Gilhooley, Michael J. J Neuroophthalmol Perspective Journal of Neuro-Ophthalmology 2023-12 2023-04-19 /pmc/articles/PMC10645107/ /pubmed/37974363 http://dx.doi.org/10.1097/WNO.0000000000001830 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the North American Neuro-Opthalmology Society. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Wong, David C. S.
Harvey, Joshua P.
Jurkute, Neringa
Thomasy, Sara M.
Moosajee, Mariya
Yu-Wai-Man, Patrick
Gilhooley, Michael J.
OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title_full OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title_fullStr OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title_full_unstemmed OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title_short OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
title_sort opa1 dominant optic atrophy: pathogenesis and therapeutic targets
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645107/
https://www.ncbi.nlm.nih.gov/pubmed/37974363
http://dx.doi.org/10.1097/WNO.0000000000001830
work_keys_str_mv AT wongdavidcs opa1dominantopticatrophypathogenesisandtherapeutictargets
AT harveyjoshuap opa1dominantopticatrophypathogenesisandtherapeutictargets
AT jurkuteneringa opa1dominantopticatrophypathogenesisandtherapeutictargets
AT thomasysaram opa1dominantopticatrophypathogenesisandtherapeutictargets
AT moosajeemariya opa1dominantopticatrophypathogenesisandtherapeutictargets
AT yuwaimanpatrick opa1dominantopticatrophypathogenesisandtherapeutictargets
AT gilhooleymichaelj opa1dominantopticatrophypathogenesisandtherapeutictargets